Skip to main content

27 June 2022

Last updated: Saturday 25 June 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

ArGEN-X builds a new antibody business

Thursday 27 January 2011

Interviewee/Contributor

Tim Van Hauwermeiren

Organisation

ArGenex BV

Organisations

Novo Seeds
VIB
Johnson & Johnson Innovation Center, London
Eli Lilly and Company
Life Sciences Partners BV
The Human Brain Project and EBRAINS
Innovative Molecules GmbH
Merus B.V.
Polyplus-Transfection SA
Verona Pharma Plc

Interviewees and Contributers

Mark Rothera
Jennifer Cubino
Jon Rees
Ed Corbett
Erik van den Berg
Janet Lambert
Deborah O-Neil
Patrick Verheyen
Paula Salmikangas and Björn Carlsson
Philippe Archinard

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Colin McCracken becomes CEO of Evonetix

Saturday 25 June 2022

Valo appoints Hemanshu Shah as CBO

Saturday 25 June 2022

David Gilman to head business strategy at ADC Therapeutics

Saturday 25 June 2022

CureVac appoints new chief development officer

Saturday 25 June 2022

Steffen Thirstrup becomes CMO at the EMA

Saturday 25 June 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form